Stocks and Investing
Stocks and Investing
Tue, November 6, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, November 5, 2018
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Alethia Young Downgraded (ADVM) to Hold and Decreased Target to $40 on, Nov 5th, 2018
Alethia Young of Cantor Fitzgerald, Downgraded "Adverum Biotechnologies, Inc." (ADVM) to Hold and Decreased Target from $120 to $40 on, Nov 5th, 2018.
Alethia has made no other calls on ADVM in the last 4 months.
There are 2 other peers that have a rating on ADVM. Out of the 2 peers that are also analyzing ADVM, all agree with Alethia's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Edward Nash of "SunTrust Robinson Humphrey" Downgraded from Strong Buy to Hold on, Friday, November 2nd, 2018
- Reni Benjamin of "Raymond James" Downgraded from Buy to Hold on, Friday, November 2nd, 2018